The effects of a hirudin/liposome complex on a diabetic nephropathy rat model
Basic science / preclinical published in BMC complementary and alternative medicine (2019)
Abstract
BACKGROUND: Hirudin, an extract from Hirudo spp., is an anticoagulant used to treat a variety of renal diseases, including diabetic nephropathy (DN). Currently, hirudin has to be used at high dosages to treat DN because it poorly targets the kidneys, although at high dosages it can have severe side effects. Developing a targeted drug delivery system for hirudin, then, could boost its positive therapeutic effects while lowering the risk of side effects. Liposomes have been demonstrated to have significant renal targeting potential, but here we show that a hirudin-loaded liposome is an effective delivery method for patients with DN. METHOD: In this study, we prepared a hirudin/liposome complex and tested its efficacy by injecting it into a rat model. We then compared the renal accumulation of hirudin between complex-injected rat models and rat models that received injections of hirudin alone. We also investigated the mechanisms behind the complex's effects. RESULT: The hirudin/liposome complex increased the accumulation of hirudin in kidney tissues and relieved the renal injury in DN rat models. Moreover, the hirudin/liposome complex down-regulated the expression of TGF-β1 and VEGF in the kidneys. CONCLUSION: We demonstrated that a hirudin/liposome complex can have a significant positive effect on DN. The mechanism may be that the complex inhibits the expression of VEGF and TGF-β1.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Hirudin, an extract from Hirudo spp. , is an anticoagulant used to treat a variety of renal diseases, including diabetic nephropathy (DN).
Why This Matters for Hirudotherapy
This study examined a hirudin/liposome complex as a kidney-targeted delivery system for hirudin—the signature anticoagulant derived from Hirudo spp.—in a rat model of diabetic nephropathy, comparing renal hirudin accumulation, renal injury outcomes, and renal TGF-β1 and VEGF expression against hirudin administered alone. For the hirudotherapy field and study of the leech salivary secretome, this work is directly relevant because it investigates pharmaceutical optimization of hirudin, one of the most therapeutically important leech-derived molecules, demonstrating how targeted liposomal delivery may enhance renal efficacy while reducing the dose-dependent side effects that currently limit use. However, this is a preclinical animal study using isolated hirudin rather than live leech therapy or the full salivary secretome, and its findings in a rat diabetes model cannot be assumed to translate directly to human patients.
Citation
The effects of a hirudin/liposome complex on a diabetic nephropathy rat model.
Wang H et al. · BMC complementary and alternative medicine, 2019
Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026